51264-70-1

Basic information

• Product Name: 4-FORMYL-2-METHOXY-PHENOXY-ACETIC ACID ETHYL ESTER
• Synonyms: AKOS B004340;4-FORMYL-2-METHOXY-PHENOXY-ACETIC ACID ETHYL ESTER;CHEMBRDG-BB 6473161;ETHYL (4-FORMYL-2-METHOXYPHENOXY)ACETATE;ART-CHEM-BB B004340;ASISCHEM R32808;ethyl (4-formyl-2-methoxyphenoxy)acetate(SALTDATA: FREE);ethyl 2-(4-formyl-2-methoxyphenoxy)acetate
• CAS NO: 51264-70-1
• Molecular Formula: C₁₂H₁₄O₅
• Molecular Weight: 238.24
• Mol File: 51264-70-1.mol
• Article Data: 24

Chemical Properties

• Melting Point: 94 °C(Solv: cyclohexane (110-82-7))
• Boiling Point: 358.3°Cat760mmHg
• Flash Point: 190.5°C
• Appearance: /
• Density: 1.178g/cm³
• Vapor Pressure: 2.57E-05mmHg at 25°C
• Refractive Index: 1.526
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 4-FORMYL-2-METHOXY-PHENOXY-ACETIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-FORMYL-2-METHOXY-PHENOXY-ACETIC ACID ETHYL ESTER(51264-70-1)
• EPA Substance Registry System: 4-FORMYL-2-METHOXY-PHENOXY-ACETIC ACID ETHYL ESTER(51264-70-1)

Safety Data

• Hazardous Substances Data: 51264-70-1(Hazardous Substances Data)

Usage

General Description

4-FORMYL-2-METHOXY-PHENOXY-ACETIC ACID ETHYL ESTER is a chemical compound with the molecular formula C12H14O5. It is an ester derived from the combination of 4-formyl-2-methoxy-phenoxyacetic acid and ethanol. This chemical is commonly used as an intermediate in organic synthesis and in the production of pharmaceuticals and agrochemicals. It has a variety of applications, including as a building block in the synthesis of other organic compounds and as a precursor in the manufacturing of insecticides, herbicides, and fungicides. 4-FORMYL-2-METHOXY-PHENOXY-ACETIC ACID ETHYL ESTER is a versatile compound with many potential uses in the fields of chemistry, medicine, and agriculture.

InChI:InChI=1/C12H14O5/c1-3-16-12(14)8-17-10-5-4-9(7-13)6-11(10)15-2/h4-7H,3,8H2,1-2H3

Upstream product

• 121-33-5 vanillin 
• 105-39-5 chloroacetic acid ethyl ester 
• 105-36-2 ethyl bromoacetate 
• 7382-59-4 guaiacylglycerol-β-guaiacyl ether 
• 20730-75-0 1-(4-(benzyloxy)-3-methoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propan-1-one 
• 22317-29-9 1-(4-(benzyloxy)-3-methoxyphenyl)-2-(2-methoxyphenoxy)ethan-1-one 
• 1835-12-7 3-methoxy-4-benzyloxy-α-bromoacetophenone 
• 1835-11-6 4-benzyloxy-3-methoxyacetophenone 
• 498-02-2 1-(3-methoxy-4-hydroxyphenyl)ethanone 
• 64-17-5 ethanol 
• 1660-19-1 (4-formyl-2-methoxyphenoxy)acetic acid 
• 932796-56-0 C₁₂H₁₅NO₅ 

Downstream Products

• 91641-85-9 2-(4-formyl-2-methoxyphenoxy)-N,N-dimethylacetamide 
• 1347750-39-3 1-(3-methoxy-4-hydroxyphenyl)-7-(4-oxoacetoxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione 
• 1415995-83-3 ethyl 2-[4-{bis(2-methyl-1H-indol-3-yl)methyl}-2-methoxyphenoxy]acetate 
• 1415995-42-4 ethyl 2-[4-{bis(1H-indol-3-yl)methyl}-2-methoxyphenoxy]acetate 

Relevant articles and documents

A NIR light-triggered drug delivery system using core-shell gold nanostars-mesoporous silica nanoparticles based on multiphoton absorption photo-dissociation of 2-nitrobenzyl PEG

Gold nanostars coated with a mesoporous silica shell and functionalized with poly(ethylene glycol) containing photolabile 2-nitrobenzyl moieties are able to release doxorubicin after NIR light irradiation at low power irradiance via a multiphoton absorpti

3-hydroxycurcumin-4-OCH2CO2H strontium, and synthesis, activity and application thereof

The invention discloses 3-hydroxycurcumin-4-OCH2CO2H strontium, discloses a preparation method of the 3-hydroxycurcumin-4-OCH2CO2H strontium, and discloses anti-osteoporosis activity of the 3-hydroxycurcumin-4-OCH2CO2H strontium so that the invention disc

Janus Gold Nanostars–Mesoporous Silica Nanoparticles for NIR-Light-Triggered Drug Delivery

Janus gold nanostar–mesoporous silica nanoparticle (AuNSt–MSNP) nanodevices able to release an entrapped payload upon irradiation with near infrared (NIR) light were prepared and characterized. The AuNSt surface was functionalized with a thiolated photolabile molecule (5), whereas the mesoporous silica face was loaded with a model drug (doxorubicin) and capped with proton-responsive benzimidazole-β-cyclodextrin supramolecular gatekeepers (N 1). Upon irradiation with NIR-light, the photolabile compound 5 photodissociated, resulting in the formation of succinic acid, which induced the opening of the gatekeeper and cargo delivery. In the overall mechanism, the gold surface acts as a photochemical transducer capable of transforming the NIR-light input into a chemical messenger (succinic acid) that opens the supramolecular nanovalve. The prepared hybrid nanoparticles were non-cytotoxic to HeLa cells, until they were irradiated with a NIR laser, which led to intracellular doxorubicin release and hyperthermia. This induced a remarkable reduction in HeLa cells viability.